Alimera Sciences (ALIM) News Today → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free ALIM Stock Alerts $3.49 +0.18 (+5.44%) (As of 02:54 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAlimera Sciences (NASDAQ:ALIM) Upgraded to Buy by StockNews.comamericanbankingnews.com - April 23 at 3:18 AMAlimera Sciences (NASDAQ:ALIM) Stock Rating Upgraded by StockNews.commarketbeat.com - April 22 at 11:13 PMAlimera Sciences, Inc. (NASDAQ:ALIM) Sees Large Growth in Short Interestmarketbeat.com - April 13 at 12:03 PMAlimera Sciences (NASDAQ:ALIM) Downgraded by StockNews.com to "Hold"marketbeat.com - April 12 at 11:18 PMAlimera Sciences (NASDAQ:ALIM) Lifted to Buy at StockNews.commarketbeat.com - April 4 at 11:10 PMLuckie & Company Acquires Marbury Creative Groupfinance.yahoo.com - April 3 at 8:30 AMLuckie & Co. acquires Atlanta marketing agencybizjournals.com - April 3 at 8:30 AMAlimera Sciences, Inc. (NASDAQ:ALIM) Short Interest Updatemarketbeat.com - March 29 at 7:19 AMOcular Inflammation Treatment Market InsightAce Exclusive Report 2024-2031finance.yahoo.com - March 26 at 6:20 AMAlimera Sciences (NASDAQ:ALIM) Receives New Coverage from Analysts at Maxim Groupmarketbeat.com - March 25 at 8:09 AMAlimera Sciences (NASDAQ:ALIM) Stock Price Crosses Above Two Hundred Day Moving Average of $3.53marketbeat.com - March 21 at 2:43 AMAlimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - March 20 at 4:19 PMAlimera Sciences, Inc.: Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Networkfinanznachrichten.de - March 19 at 3:12 PMAlimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Networkfinance.yahoo.com - March 19 at 8:10 AMAlimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Networkglobenewswire.com - March 19 at 8:00 AMMizuho downgrades Amylyx to Neutral after ALS trial setbackmsn.com - March 18 at 10:04 AMAlimera Sciences price target raised by $1 at H.C. Wainwright, here's whyrealmoney.thestreet.com - March 10 at 8:59 AMAlimera Sciences, Inc. (ALIM) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 9 at 2:00 PMBuy Rating Affirmed for Alimera Sciences Amid Strong Financial Performance and Promising Clinical Trialsmarkets.businessinsider.com - March 8 at 11:04 PMAlimera Sciences, Inc. (NASDAQ:ALIM) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 8 at 1:02 PMAlimera Sciences (NASDAQ:ALIM) Issues Earnings Resultsmarketbeat.com - March 8 at 11:23 AMQ4 2023 Alimera Sciences Inc Earnings Callfinance.yahoo.com - March 8 at 3:02 AMALIM Stock Earnings: Alimera Sciences Beats Revenue for Q4 2023investorplace.com - March 7 at 2:01 PMAlimera Sciences, Inc.: Alimera Sciences Reports Fourth Quarter and Full Year 2023 Resultsfinanznachrichten.de - March 7 at 12:00 PMAlimera Sciences Reports Fourth Quarter and Full Year 2023 Resultsglobenewswire.com - March 7 at 7:30 AMA Preview Of Alimera Sciences's Earningsbenzinga.com - March 6 at 3:59 PMAlimera Sciences, Inc. (NASDAQ:ALIM) Has Found A Path To Profitabilityfinance.yahoo.com - March 6 at 3:58 PMWorth Venture Partners LLC Purchases New Position in Alimera Sciences, Inc. (NASDAQ:ALIM)marketbeat.com - March 6 at 12:57 PMAlimera Sciences, Inc. (NASDAQ:ALIM) Sees Significant Drop in Short Interestmarketbeat.com - March 3 at 6:58 AMAlimera Sciences (ALIM) Set to Announce Earnings on Thursdaymarketbeat.com - March 1 at 2:55 PMAlimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate Updatefinance.yahoo.com - February 29 at 12:23 PMAIGH Capital Management LLC Takes $7.36 Million Position in Alimera Sciences, Inc. (NASDAQ:ALIM)marketbeat.com - February 16 at 12:20 PMAlimera Sciences Launches 2024 Equity Inducement Planmsn.com - February 10 at 8:55 AMThe UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN®finance.yahoo.com - February 8 at 9:22 AMAlimera Sciences (NASDAQ:ALIM) Shares Pass Above 200 Day Moving Average of $3.46marketbeat.com - February 8 at 4:24 AMAlimera Sciences (NASDAQ:ALIM) shareholders have endured a 69% loss from investing in the stock five years agofinance.yahoo.com - January 25 at 12:22 PMAlimera Completes Recruitment for the Synchronicity Studyfinance.yahoo.com - January 4 at 12:32 PMAlimera Sciences Names Elliot Maltz Chief Financial Officermarketwatch.com - January 2 at 9:31 AMAlimera Sciences Names Elliot Maltz To Succeed Russell Skibsted As CFOmarkets.businessinsider.com - January 2 at 9:31 AMAlimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - January 2 at 9:31 AMAlimera Sciences, Inc. (NASDAQ:ALIM) Sees Large Decrease in Short Interestmarketbeat.com - December 31 at 3:55 AMStockNews.com Initiates Coverage on Alimera Sciences (NASDAQ:ALIM)marketbeat.com - December 15 at 1:20 AMAlimera Sciences Appoints Todd Wood as President of U.S. Operations and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - December 12 at 9:15 AMmarketbeat.com - November 17 at 9:36 AMAlimera Appoints Maggie A. Pax to Its Board of Directorsfinance.yahoo.com - November 8 at 6:55 PMAlimera Announces Scientific Data Highlighting ILUVIEN® To Be Presented at the American Academy of Ophthalmologyfinance.yahoo.com - October 31 at 8:40 AMAlimera Sciences, Inc. (NASDAQ:ALIM) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - October 27 at 1:42 PMAlimera Sciences Reports Third Quarter 2023 Resultsmarkets.businessinsider.com - October 27 at 8:42 AMAlimera Sciences GAAP EPS of -$0.06 misses by $0.18, revenue of $23.4M beats by $0.68Mmsn.com - October 26 at 3:48 PMAlimera Sciences, Inc.: Alimera Sciences Reports Third Quarter 2023 Resultsfinanznachrichten.de - October 26 at 10:34 AM Get Alimera Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ALIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. ALIM Media Mentions By Week ALIM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALIM News Sentiment▼0.000.33▲Average Medical News Sentiment ALIM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALIM Articles This Week▼22▲ALIM Articles Average Week Get Alimera Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ALIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ATOS News Today VERU News Today LFCR News Today TRVI News Today OMER News Today ZVRA News Today RIGL News Today OGI News Today SKYE News Today IVA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALIM) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alimera Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
